Cargando…

Long-term outcomes of drug-eluting stent implantation in patients with symptomatic extra- and intracranial atherosclerotic stenoses

OBJECTIVE: Implantation of drug-eluting stents (DES) for extra- and intracranial atherosclerotic stenoses is an emerging topic. It has the potential benefit of preventing recurrent stroke with a reduced rate of in-stent restenosis (ISR). METHODS: Patients who underwent extra- or intracranial stentin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Junhyung, Ban, Seung Pil, Kim, Young Deok, Kwon, O-Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Cerebrovascular Surgeons and Korean NeuroEndovascular Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820269/ https://www.ncbi.nlm.nih.gov/pubmed/33050686 http://dx.doi.org/10.7461/jcen.2020.E2020.09.001

Ejemplares similares

Usefulness of Stent Implantation for Treatment of Intracranial Atherosclerotic Stenoses
por: Kim, Kuk Seon, et al.
Publicado: (2012)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
por: Park, Soonchan, et al.
Publicado: (2013)

Comparison of Full Lesion Coverage versus Spot Drug-Eluting Stent Implantation for Coronary Artery Stenoses
por: Kim, Seunghwan, et al.
Publicado: (2014)

Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease
por: Hassan, Ameer E., et al.
Publicado: (2020)

Predictors of hyperperfusion syndrome after stent implantation in symptomatic intracranial atherosclerotic stenosis
por: Yan, Long, et al.
Publicado: (2022)

Simultaneous Stenting for Symptomatic Tandem Extracranial and Intracranial Posterior Circulation Stenoses: Long-Term Outcomes and Procedural Experience
por: Jia, Zichang, et al.
Publicado: (2021)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019)

Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options
por: Krasteva, Marina Petrova, et al.
Publicado: (2020)

Two Cases of Immediate Stent Fracture after Zotarolimus-Eluting Stent Implantation
por: Lee, Pil Hyung, et al.
Publicado: (2015)

Center volume and the outcomes of percutaneous transluminal angioplasty and stenting in patients with symptomatic intracranial vertebrobasilar stenoses: A meta-analysis
por: Mao, Ying, et al.
Publicado: (2018)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Endovascular treatment of patients with high-risk symptomatic intracranial vertebrobasilar stenoses: long - term outcomes
por: Djurdjevic, Tanja, et al.
Publicado: (2019)

Intracranial Stenting Using a Drug-Eluting Stent for Moyamoya Disease Involving Supraclinoid Internal Carotid Artery: A Case Report
por: KIM, Tackeun, et al.
Publicado: (2014)

Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation
por: Choi, Hyun-Chul, et al.
Publicado: (2010)

Long-Term Outcomes of Placement of a Single Transverse Stent through the Anterior Communicating Artery via the Nondominant A1 in Coil Embolization of Wide-Necked Anterior Communicating Artery Aneurysms
por: Ban, Seung Pil, et al.
Publicado: (2022)

Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients
por: Feng, Zhengzhe, et al.
Publicado: (2015)

Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
por: Si, Jiang-Hua, et al.
Publicado: (2022)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Association between Leukoaraiosis and Symptomatic Intracranial Large Artery Stenoses and Occlusions: the Chinese Intracranial Atherosclerosis (CICAS) Study
por: Duan, Wanying, et al.
Publicado: (2018)

Novel usage of everolimus-eluting coronary stent for intracranial atherosclerotic disease: a technical report and case series
por: Coulibaly, Nangorgo Jean Oumar, et al.
Publicado: (2023)

Treatment of Intracranial Atherosclerotic Disease with a Balloon-Expandable Paclitaxel Eluting Stent: Procedural Safety, Efficacy and Mid-Term Patency
por: Vajda, Z., et al.
Publicado: (2012)

Severe Acute Stent Malapposition After Drug‐Eluting Stent Implantation: Effects on Long‐Term Clinical Outcomes
por: Lee, Seung‐Yul, et al.
Publicado: (2019)

Platelet-Derived Growth Factor Is Associated with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
por: Kim, Kyeong Joon, et al.
Publicado: (2021)

Current Status and Future Perspective of Stenting for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis
por: Li, Zhong-Hao, et al.
Publicado: (2017)

Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Disease
por: Short, Jody L., et al.
Publicado: (2011)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Nationwide Mortality Data after Flow-Diverting Stent Implantation in Korea
por: Kim, Tackeun, et al.
Publicado: (2018)

Coronary Artery Perforation Following Implantation of a Drug-Eluting Stent Rescued by Deployment of a Covered Stent in Symptomatic Myocardial Bridging
por: Zhang, Man, et al.
Publicado: (2010)

Very Late Stent Thrombosis after Drug-Eluting Stent Implantation in a Patient without Aspirin and Clopidogrel Resistance
por: Lim, Sang Yup, et al.
Publicado: (2008)

Complications and long-term in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors
por: Yang, Lei, et al.
Publicado: (2023)

Long-term Clinical Outcomes of Drug-Eluting Stent Malapposition
por: Lee, Seung-Yul, et al.
Publicado: (2020)

Predictors of diffuse-type in-stent restenosis following drug-eluting stent implantation
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Zotarolimus-eluting stent-induced hypersensitivity pneumonitis
por: Shin, Hong-Won, et al.
Publicado: (2013)

Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
por: Park, Jong-Ho, et al.
Publicado: (2017)

Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021)

Stent Fracture after Everolimus-Eluting Stent Implantation
por: Almasood, Ali S., et al.
Publicado: (2011)

Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2015)

Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020)

Plaque morphology in acute symptomatic intracranial atherosclerotic disease
por: Leung, Thomas W, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4j2k1aqnfoe5gf7ib7u46kf1cs